ANDA 209945, held by Eci Pharms LLC. Trientine Hydrochloride.
As of Nov 15, 2026, ANDA 209945 (Trientine Hydrochloride), held by Eci Pharms LLC, was first approved by FDA on Aug 13, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 13, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trientine Hydrochloride250MG ยท capsule;oral | Trientine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
